A National Study in Patients With Unexplained Splenomegaly
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)
- Status
- COMPLETED
- Phase
- PHASE3
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)
- Status
- COMPLETED
- Phase
- PHASE3
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)
- Status
- COMPLETED
- Phase
- PHASE3
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks
- Status
- COMPLETED
- Phase
- PHASE4
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
- Status
- TERMINATED
- Phase
- PHASE1
The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma
- Status
- COMPLETED
- Phase
- PHASE4
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Status
- RECRUITING
- Phase
- N/A
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
- Status
- COMPLETED
- Phase
- PHASE3
Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Hydroxychloroquine in Outpatient Adults With COVID-19
- Status
- TERMINATED
- Phase
- PHASE1
Sarilumab COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2